Fair Value Inputs, Revenue Volatility

No definition available.

Name:	iart_FairValueInputsRevenueVolatility
Namespace Prefix:	iart_
Data Type:	num:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

For contingent consideration arrangements recognized in connection with a business combination, this element represents an estimate of the high-end of the potential range (undiscounted) of the consideration which may be paid.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (c)(3)
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479

+ Details

Name:	us-gaap_BusinessCombinationContingentConsiderationArrangementsRangeOfOutcomesValueHigh
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of liability recognized arising from contingent consideration in a business combination.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 50
-Paragraph 1
-Subparagraph (c)(1)
-URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 35
-Paragraph 1
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=116859824&loc=d3e6819-128478

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 805
-SubTopic 30
-Section 25
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476

+ Details

Name:	us-gaap_BusinessCombinationContingentConsiderationLiability
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Value of input used to measure debt instrument, including, but not limited to, convertible and non-convertible debt.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 820
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (bbb)(2)
-URI http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258

+ Details

Name:	us-gaap_DebtInstrumentMeasurementInput
Namespace Prefix:	us-gaap_
Data Type:	xbrli:decimalItemType
Balance Type:	na
Period Type:	instant

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_LossContingenciesLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Amount of cash outflow, not made soon after acquisition date of business combination, to settle contingent consideration liability up to amount recognized at acquisition date, including, but not limited to, measurement period adjustment and less amount paid soon after acquisition date.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 15
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3291-108585

+ Details

Name:	us-gaap_PaymentForContingentConsiderationLiabilityFinancingActivities
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Definition

Amount of cash outflow, made soon after acquisition date of business combination, to settle contingent consideration liability.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 13
-Subparagraph (d)
-URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585

+ Details

Name:	us-gaap_PaymentForContingentConsiderationLiabilityInvestingActivities
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	duration

- Details

Name:	us-gaap_BusinessAcquisitionAxis=iart_ConfluentSurgicalInc.Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputDiscountRateMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FairValueByLiabilityClassAxis=iart_ContingentConsiderationLiabilityMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ContingentConsiderationByTypeAxis=iart_CashConsiderationOneMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ContingentConsiderationByTypeAxis=iart_CashConsiderationTwoMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_BusinessAcquisitionAxis=iart_DermaSciencesMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ContingentConsiderationByTypeAxis=iart_BioDEarnoutPaymentsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ContingentConsiderationByTypeAxis=iart_ProductPaymentContingentConsiderationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ContingentConsiderationByTypeAxis=iart_MedihoneyEarnoutPaymentsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

COMMITMENTS AND CONTINGENCIES - Narrative (Details) $ in Millions			1 Months Ended		3 Months Ended
	May 25, 2017 USD ($)	Feb. 24, 2017 USD ($)	Oct. 31, 2018 USD ($)	Aug. 31, 2017 USD ($)	Jun. 30, 2018 USD ($)	Jun. 30, 2019 USD ($)	Dec. 31, 2018 USD ($)	Mar. 31, 2018 USD ($)	Feb. 14, 2017 USD ($)	Jan. 15, 2014 USD ($)
Confluent Surgical, Inc.
Loss Contingencies [Line Items]
Maximum contingent consideration										$ 30.0
Contingent consideration, liability								$ 19.0
Payment for contingent consideration			$ 5.0
Confluent Surgical, Inc. \| Measurement Input, Discount Rate \| Contingent Consideration Liability
Loss Contingencies [Line Items]
Discounted cash flow model, measurement input										0.022
Confluent Surgical, Inc. \| Cash Consideration One
Loss Contingencies [Line Items]
Maximum contingent consideration										$ 25.0
Confluent Surgical, Inc. \| Cash Consideration Two
Loss Contingencies [Line Items]
Maximum contingent consideration										$ 5.0
Derma Sciences \| BioD Earnout Payments
Loss Contingencies [Line Items]
Maximum contingent consideration		$ 26.5							$ 26.5
Contingent consideration, liability		$ 9.1
Payment for contingent consideration				$ 4.8
Revenue volatility percentage		13.50%
Derma Sciences \| BioD Earnout Payments \| Measurement Input, Discount Rate
Loss Contingencies [Line Items]
Discounted cash flow model, measurement input		0.030
Derma Sciences \| Product Payment Contingent Consideration
Loss Contingencies [Line Items]
Payment for contingent consideration liability	$ 26.6
Derma Sciences \| Medihoney Earnout Payments
Loss Contingencies [Line Items]
Maximum contingent consideration		$ 5.0
Contingent consideration, liability					$ 0.2	$ 0.2	$ 0.2
Payment for contingent consideration					$ 2.0
Revenue volatility percentage		27.50%
Derma Sciences \| Medihoney Earnout Payments \| Measurement Input, Discount Rate
Loss Contingencies [Line Items]
Discounted cash flow model, measurement input		0.045